UnknownNot Applicable

Efficacy and Safety of 1565-nm Non-ablative Fractional Laser Versus Long-pulsed 1064-nm Nd:YAG Laser in the Treatment of Enlarged Facial Pores

China27 participantsStarted 2018-10-27

Plain-language summary

Facial pores are visible openings of pilosebaceous follicles, it is one of the important factors that affect the appearance of facial skin. This study aims to evaluate and compare the Efficacy and safety of 1565 nm non-ablative fractional laser (NAFL) and long-pulsed 1064 nm Nd:YAG laser (LPNY) in the treatment of enlarged facial pores.

Who can participate

Age range20 Years – 50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * subjects with enlarged facial pores who were screened by a designated dermatologist Exclusion Criteria: * infectious skin disease or systemic disease; skin tumors; pregnancy and lactation; patients with a history of glucocorticoids, immunosuppressant drugs and other drugs within 4 weeks; a history of keloid; a medical history of chemical peelings, filler injections, plastic surgery, or laser therapy on the face in the last 3 months

What they're measuring

Change from baseline in Pore number

Timeframe: from baseline(T0) at two months after last treatment(T1)

Subjective evaluations for improvement in appearance of facial pores

Timeframe: two months after last treatment(T1)

Satisfaction evaluations for treatment results

Timeframe: two months after last treatment(T1)

Trial details

NCT IDNCT05360043

SponsorSecond Affiliated Hospital, School of Medicine, Zhejiang University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-04-05

Contact for this trial

Ying Wang, M.D

+86 15168229499 wangyingme@zju.edu.cn

View on ClinicalTrials.gov More Enlarged Facial Pores trials